These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2535804)

  • 21. Association of diurnal variations in hypothalamic but not cortical opiate ([3H]-naloxone)-binding sites with the ability of naloxone to induce LH release in the prepubertal female rat.
    Jacobson W; Wilkinson M
    Neuroendocrinology; 1986; 44(1):132-5. PubMed ID: 3024054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desensitization of brain opiate receptor mechanisms by gonadal steroid treatments that stimulate luteinizing hormone secretion.
    Berglund LA; Derendorf H; Simpkins JW
    Endocrinology; 1988 Jun; 122(6):2718-26. PubMed ID: 2836173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation.
    Petraglia F; Sutton S; Vale W; Plotsky P
    Endocrinology; 1987 Mar; 120(3):1083-8. PubMed ID: 3542513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of gonadotropin-releasing hormone (GnRH) receptor expression in the posterior mediobasal hypothalamus by steroid hormones: implication of GnRH neuronal activity.
    Seong JY; Kang SS; Kam K; Han YG; Kwon HB; Ryu K; Kim K
    Brain Res Mol Brain Res; 1998 Jan; 53(1-2):226-35. PubMed ID: 9473680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disinhibition from opioid influence augments hypothalamic neuropeptide Y (NPY) gene expression and pituitary luteinizing hormone release: effects of NPY messenger ribonucleic acid antisense oligodeoxynucleotides.
    Xu B; Sahu A; Kalra PS; Crowley WR; Kalra SP
    Endocrinology; 1996 Jan; 137(1):78-84. PubMed ID: 8536645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-arginine/nitric oxide amplifies the magnitude and duration of the luteinizing hormone surge induced by estrogen: involvement of neuropeptide Y.
    Bonavera JJ; Kalra PS; Kalra SP
    Endocrinology; 1996 May; 137(5):1956-62. PubMed ID: 8612536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A decline in endogenous opioid influence during the steroid-induced hypersecretion of luteinizing hormone in the rat.
    Gabriel SM; Berglund LA; Simpkins JW
    Endocrinology; 1986 Feb; 118(2):558-61. PubMed ID: 3510853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that catecholaminergic and peptidergic (luteinizing hormone-releasing hormone) neurons in suprachiasmatic-medial preoptic, medial basal hypothalamus and median eminence are involved in estrogen-negative feedback.
    Advis JP; McCann SM; Negro-Vilar A
    Endocrinology; 1980 Oct; 107(4):892-901. PubMed ID: 6997020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restraining action of GABA on estradiol-induced LH surge in the rat: GABA activity in brain nuclei and effects of GABA mimetics in the medial preoptic nucleus.
    Seltzer AM; Donoso AO
    Neuroendocrinology; 1992 Jan; 55(1):28-34. PubMed ID: 1319004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the progesterone receptor in restrained glutamic acid decarboxylase gene expression in the hypothalamus during the preovulatory luteinizing hormone surge.
    Brann D; Unda R; Mahesh VB
    Neuroendocrinology; 2002 Nov; 76(5):283-9. PubMed ID: 12457039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors.
    Jain MR; Pu S; Kalra PS; Kalra SP
    Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progesterone modulation of the luteinizing hormone surge: regulation of hypothalamic and pituitary progestin receptors.
    Attardi B
    Endocrinology; 1984 Dec; 115(6):2113-22. PubMed ID: 6541995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of glutamate and aspartate from the preoptic area during the progesterone-induced LH surge: in vivo microdialysis studies.
    Ping L; Mahesh VB; Wiedmeier VT; Brann DW
    Neuroendocrinology; 1994 Apr; 59(4):318-24. PubMed ID: 7911230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic changes in hypothalamic angiotensin II levels and release in association with progesterone-induced luteinizing hormone surge.
    Phillips MI; Wang H; Kimura B; Rejtman M; Koduri P; Kalra SP
    Endocrinology; 1993 Apr; 132(4):1637-42. PubMed ID: 8462463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-1 inhibits the ovarian steroid-induced luteinizing hormone surge and release of hypothalamic luteinizing hormone-releasing hormone in rats.
    Kalra PS; Sahu A; Kalra SP
    Endocrinology; 1990 Apr; 126(4):2145-52. PubMed ID: 2180683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of glutamate receptor subunits in the hypothalamus of the female rat during the afternoon of the proestrous luteinizing hormone surge and effects of antiprogestin treatment and aging.
    Brann DW; Zamorano PL; De Sevilla L; Mahesh VB
    Neuroendocrinology; 2005; 81(2):120-8. PubMed ID: 15961958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that atrazine and diaminochlorotriazine inhibit the estrogen/progesterone induced surge of luteinizing hormone in female Sprague-Dawley rats without changing estrogen receptor action.
    McMullin TS; Andersen ME; Nagahara A; Lund TD; Pak T; Handa RJ; Hanneman WH
    Toxicol Sci; 2004 Jun; 79(2):278-86. PubMed ID: 15056801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the binding characteristics of the mu, delta and kappa subtypes of the opioid receptor in the hypothalamus of the normal cyclic ewe and in the ovariectomised ewe following treatment with ovarian steroids.
    Thom B; Canny BJ; Cowley M; Wright PJ; Clarke IJ
    J Endocrinol; 1996 Jun; 149(3):509-18. PubMed ID: 8691110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone: effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus.
    Attardi B
    Endocrinology; 1981 Apr; 108(4):1487-96. PubMed ID: 7472278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide Y Y2 receptors in hypothalamic neuroendocrine areas are up-regulated by estradiol and decreased by progesterone cotreatment in the ovariectomized rat.
    Parker SL; Carroll BL; Kalra SP; St-Pierre S; Fournier A; Crowley WR
    Endocrinology; 1996 Jul; 137(7):2896-900. PubMed ID: 8770911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.